Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter E Haefeli

Showing results (171-180 of 351) with videos related to

Pageof 36
Sort By:
Antimicrobial Agents and Chemotherapy|October 28, 2005
In vitro assessment of methylene blue on chloroquine-sensitive and -resistant Plasmodium falciparum strains reveals synergistic action with artemisininsMonique Akoachere, Kathrin Buchholz, Elisabeth Fischer, et al.
Analytical and Bioanalytical Chemistry|January 19, 2012
Quantification of femtomolar concentrations of the CYP3A substrate midazolam and its main metabolite 1'-hydroxymidazolam in human plasma using ultra performance liquid chromatography coupled to tandem mass spectrometryJürgen Burhenne, Birte Halama, Monika Maurer, et al.
Patient Preference and Adherence|March 19, 2020
Methods to Assess Patient Preferences in Old Age Pharmacotherapy - A Systematic ReviewAnnette Eidam, Anja Roth, André Lacroix, et al.
International Journal of Cancer|November 21, 2022
Molecular prediction of clinical response to anti-PD-1/anti-PD-L1 immune checkpoint inhibitors: New perspectives for precision medicine and mass spectrometry-based investigationsRémi Longuespée, Dirk Theile, Inka Zörnig, et al.
British Journal of Clinical Pharmacology|March 27, 2019
Perpetrator effects of ciclosporin (P-glycoprotein inhibitor) and its combination with fluconazole (CYP3A inhibitor) on the pharmacokinetics of rivaroxaban in healthy volunteersAntonia Brings, Marie-Louise Lehmann, Kathrin I Foerster, et al.
Pharmacology Research & Perspectives|April 18, 2024
Coadministration of fluconazole to boost subtherapeutic sirolimus concentrations: A case reportCamilo Scherkl, Andreas D Meid, Sven E Cuntz, et al.
Clinical Epidemiology|November 11, 2020
Using the Causal Inference Framework to Support Individualized Drug Treatment Decisions Based on Observational Healthcare DataAndreas D Meid, Carmen Ruff, Lucas Wirbka, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 31, 2011
Cellular pharmacokinetic/pharmacodynamic relationship of platinum cytostatics in head and neck squamous cell carcinoma evaluated by liquid chromatography coupled to tandem mass spectrometryDirk Theile, Jan-Christoph Detering, Christel Herold-Mende, et al.
International Journal of Molecular Sciences|May 27, 2023
Desorption Kinetics Evaluation for the Development of Validated Desorption Electrospray Ionization-Mass Spectrometric Assays for Drug Quantification in Tissue SectionsMargaux Fresnais, Siwen Liang, Deniz Seven, et al.
Journal of the American Geriatrics Society|December 27, 2016
Is Polypharmacy Associated with Frailty in Older People? Results From the ESTHER Cohort StudyKai-Uwe Saum, Ben Schöttker, Andreas D Meid, et al.
Pageof 36

Showing results (171-180 of 351) with videos related to

Sort By:
Pageof 36
Antimicrobial Agents and Chemotherapy|October 28, 2005
In vitro assessment of methylene blue on chloroquine-sensitive and -resistant Plasmodium falciparum strains reveals synergistic action with artemisininsMonique Akoachere, Kathrin Buchholz, Elisabeth Fischer, et al.
Analytical and Bioanalytical Chemistry|January 19, 2012
Quantification of femtomolar concentrations of the CYP3A substrate midazolam and its main metabolite 1'-hydroxymidazolam in human plasma using ultra performance liquid chromatography coupled to tandem mass spectrometryJürgen Burhenne, Birte Halama, Monika Maurer, et al.
Patient Preference and Adherence|March 19, 2020
Methods to Assess Patient Preferences in Old Age Pharmacotherapy - A Systematic ReviewAnnette Eidam, Anja Roth, André Lacroix, et al.
International Journal of Cancer|November 21, 2022
Molecular prediction of clinical response to anti-PD-1/anti-PD-L1 immune checkpoint inhibitors: New perspectives for precision medicine and mass spectrometry-based investigationsRémi Longuespée, Dirk Theile, Inka Zörnig, et al.
British Journal of Clinical Pharmacology|March 27, 2019
Perpetrator effects of ciclosporin (P-glycoprotein inhibitor) and its combination with fluconazole (CYP3A inhibitor) on the pharmacokinetics of rivaroxaban in healthy volunteersAntonia Brings, Marie-Louise Lehmann, Kathrin I Foerster, et al.
Pharmacology Research & Perspectives|April 18, 2024
Coadministration of fluconazole to boost subtherapeutic sirolimus concentrations: A case reportCamilo Scherkl, Andreas D Meid, Sven E Cuntz, et al.
Clinical Epidemiology|November 11, 2020
Using the Causal Inference Framework to Support Individualized Drug Treatment Decisions Based on Observational Healthcare DataAndreas D Meid, Carmen Ruff, Lucas Wirbka, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 31, 2011
Cellular pharmacokinetic/pharmacodynamic relationship of platinum cytostatics in head and neck squamous cell carcinoma evaluated by liquid chromatography coupled to tandem mass spectrometryDirk Theile, Jan-Christoph Detering, Christel Herold-Mende, et al.
International Journal of Molecular Sciences|May 27, 2023
Desorption Kinetics Evaluation for the Development of Validated Desorption Electrospray Ionization-Mass Spectrometric Assays for Drug Quantification in Tissue SectionsMargaux Fresnais, Siwen Liang, Deniz Seven, et al.
Journal of the American Geriatrics Society|December 27, 2016
Is Polypharmacy Associated with Frailty in Older People? Results From the ESTHER Cohort StudyKai-Uwe Saum, Ben Schöttker, Andreas D Meid, et al.
Pageof 36